BrainsWay Ltd.
NASDAQ: BWAY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Hadar Levy
- Employees
- 120
- Headquarters
- Jerusalem, Israel
- IPO year
- 2019
- Market cap
- $564.8M
- Website
- https://www.brainsway.com
Loading BWAY…
Loading profile data…Frequently asked questions about BWAY
What does BrainsWay Ltd. (BWAY) do?
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation...
Where does BWAY trade?
BrainsWay Ltd. (BWAY) trades on the NASDAQ Global Market.
What sector is BWAY in?
BrainsWay Ltd. (BWAY) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of BrainsWay Ltd.?
Hadar Levy is the chief executive officer of BrainsWay Ltd. (BWAY).
Where is BrainsWay Ltd. headquartered?
BrainsWay Ltd. is headquartered in Israel.
Does BWAY pay a dividend?
BrainsWay Ltd. (BWAY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BWAY go public?
BrainsWay Ltd. (BWAY) completed its initial public offering in 2019.
Is BWAY an ADR?
Yes — BWAY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. BrainsWay Ltd. reporting and dividends follow the underlying issuer.